Month: May 2021

Release – ProMIS Neurosciences initiates commercialization of COVID-19 serology assay

Posted on by Admin


ProMIS Neurosciences initiates commercialization of COVID-19 serology assay

 

Seasoned industry executive and entrepreneur, Owen Dempsey to lead the effort for ProMIS

TORONTO, Ontario and CAMBRIDGE, Massachusetts – May 25, 2021– ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced that it has initiated commercialization of its COVID-19 serology assay and has appointed Owen Dempsey to lead the commercialization program.

Owen’s professional work for the past 25 years has been to build companies founded to discover and commercialize antibodies in applications including life science research, pharmaceutical drug discovery, clinical diagnostics and therapeutic treatment of cancer, AIDS and other serious illness.  He has led private, venture-backed as well as NASDAQ-listed companies and is a past board member of ALDA, the Analytical, Life Science & Diagnostics Association.

 “I am delighted to lead this opportunity on behalf of ProMIS Neurosciences”, stated Owen Dempsey. “Our serology assay commercialization efforts will be targeting the need for a highly accurate test to detect, quantify and characterize antibodies against the virus causing COVID-19, either as a consequence of contracting the viral disease or in response to vaccination. Our initial focus will be on commercialization to the medical and public health community, vaccine developers, pharmaceutical companies, governmental agencies and other organizations.”

This advanced serology test developed by ProMIS Neurosciences measures not only serum antibodies to SARS-CoV-2, the novel coronavirus causing COVID-19, but also their protective activity against infection.  The assay simultaneously assesses antibody levels in the blood of study participants and their neutralizing activity against the original strain of SARS-CoV-2 as well as emerging variants.  Additional variants can be added to the assay as they are identified.  The assay utilizes an advanced, high-throughput, sensitive and accurate surface plasmon resonance (SPR) technology as opposed to traditional ELISA (enzyme-linked immunosorbent assay) methods.  

In commercializing an advanced serology testing platform, we aim to meet the needs of the medical community and investigators in academia, industry and government working to assess response and durability of response to vaccines as well as to monitor and assess antibody response to emerging strains of the virus..  As reported in the scientific literature, our accurate and sensitive format is capable of measuring neutralizing antibodies that inhibit coronavirus RBD binding to the human ACE2 receptor. This provides a powerful surrogate measure of antibody immunity without the need for live virus or pseudovirus formats. This and similar collaborative efforts may help to guide the need for boosters or modified vaccines addressing emerging strains and will inform the medical community’s preparedness to meet similar public threats to global health in the years ahead. 

It is important to note, as stated above that the initial marketing and commercialization of the assay will be directed only to organizations such as vaccine manufacturers, pharmaceutical companies and government organizations at the national and state/provincial level. The assay is not currently available to private individual consumers or the general public.

About ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc. is a development stage biotechnology company focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). The Company’s proprietary target discovery engine is based on the use of two complementary techniques. The Company applies its thermodynamic, computational discovery platform -ProMIS and Collective Coordinates – to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique approach, the Company is developing novel antibody therapeutics for AD, ALS and PD.  ProMIS is headquartered in Toronto, Ontario, with offices in Cambridge, Massachusetts. ProMIS is listed on the Toronto Stock Exchange under the symbol PMN, and on the OTCQB Venture Market under the symbol ARFXF.

 

For further information about ProMIS Neurosciences, please consult the Company’s website at:  www.promisneurosciences.com

 

Follow us on Twitter

Like us on LinkedIn

 

For Investor Relations please contact:

Alpine Equity Advisors
Nicholas Rigopulos, President
nick@alpineequityadv.com
Tel. 617 901-0785

 

 

The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. Specifically, the Company’s effort to commercialize its COVID-19 serology assay may not succeed due to many known and unknown factors, including the emergence of competing products, lack of market acceptance for its test, the cost of production relative to the revenue generated, and/or changes in the need for COVID-19 serology tests. All forward-looking statements are based on the Company’s current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Allegiant Discovers Bonanza Gold and Silver Grades at Eastside

Posted on by Admin


Allegiant Discovers Bonanza Gold and Silver Grades at Eastside

 

  • HOLE 243 – 148 METRES (486 FEET) OF 2.6 G/T GOLD
    (including 14 METRES (45 FEET) OF 21.9 G/T GOLD)
    (including 20 METRES (65 FEET) OF 173.8 G/T SILVER)
  • HOLE 239 – 3 METRES (10 FEET) OF 39.0 G/T GOLD

RENO, Nev., May 26, 2021 (GLOBE NEWSWIRE) — Allegiant Gold Ltd. (“Allegiant” or the “Company”) (AUAU: TSX-V) (AUXXF: OTCQX) is very pleased to announce bonanza grades in the best drill results to date in the Original Pit Zone, at the 100% owned Eastside gold project in Nevada.   Eastside presently hosts a current NI 43-101 pit-constrained Inferred resource of 996,000 ounces of gold and 7.8 million ounces of silver* and is open in all directions.

Peter Gianulis, CEO of Allegiant Gold, commented: “The results from the recent drill program at Eastside are simply the best received since Allegiant made the initial discovery. The project has exceeded our expectations and continues to improve and positively surprise us with its potential. We remain focused on executing our business plan and are well on our way to outlining a multi-million-ounce deposit at Eastside.”

Highlights of the 9-hole (3,673 metres) RC drill program:

  • Hole 243 included 2.55 g/t Au over 147.8 metres (3.17 g/t Au over 117.3m)
  • Hole 243 is the best drill intercept to date at the project
  • Hole 243 was a 100m step-out from the closest hole in the Original Pit and is open west, east and south
  • Hole 243 is well within an open-pit modeling scenario
  • Significant silver in Holes 243 and 239
  • Strong gold intercepts in Holes 239, 243, 244 and 245
  • Mineralization encountered in 7 of 9 holes
  • Eastside remains open in all directions and at depth in both the Original Pit Zone and the Castle Zone

Allegiant has drilled over 210 holes over the past 8 years in building a significant 1mm ounce gold inferred resource. Over 284 metres of the 428 metres drilled were mineralized in Hole 243 and, utilizing a 0.10 g/t Au cut-off, the hole delivered 2.55 g/t Au over 147.8 metres (3.17 g/t Au over 117.3m using a 0.20 g/t Au cut-off) commencing from a depth of 172 metres. Equally important is that Hole 243 ended in gold mineralization, with the bottom running 12.2m of 2.24 g/t Au (within a 55m interval of 0.92 g/t Au). Excellent silver mineralization was also encountered (see comment on Significant Silver Intercepts below).

Strong Gold Intercepts in Hole 239, 244 and 245
The success during the recent drill program was not limited solely to Hole 243. Excellent grades and intercepts were found in additional holes with strong mineralization occurring at the bottom of the holes implying the deposit continues to remain open at depth.

  Hole 239 111.3m of 1.45 g/t Au including 3.1 metres of 39 g/t at the bottom of the hole.
  Hole 244 76 metres of hole is mineralized with best intercept being 6.1m of 1.48 g/t Au
  Hole 245 32 metres of 3.4 g/t Au from relatively shallow depths (177m)

Significant Silver Intercepts in Holes 239, 243 and 244
Excellent silver intercepts were also encountered during this most recent drilling program. Using a 10 g/t Ag cutoff, Hole 239 encountered 6.1 metres of 113.35 g/t Ag at the bottom of the hole leading us to believe that it remains wide-open at depth. In Hole 243, an intercept of 93.3 g/t Ag over 44.2 metres was identified. Other silver intercepts were found in Hole 241 and Hole 244. The Original Pit Zone at Eastside hosts approximately 7.8 million ounces of silver per the most recent 43-101 compliant resource estimate dated January 2020. Allegiant continues to believe that there remains significant upside potential to discover additional silver, though gold continues to be the primary mineralization.

Geological Comment
Gold and silver at the Original Pit Zone is hosted mainly in young rhyolite domes and dikes (7.2 MYBP) cutting through andesite flows and lahar, lacustrine tuffs, and rhyodacite flows and plugs. Eighty five percent of the drilled gold intercepts are hosted in rhyolite. Important alteration includes multiple generations of quartz in stock works, replacement illite, adularia (both as flooding and in veins), and a variety of iron oxides mostly filling fractures. The domes at the Original Pit are the northernmost two of a highly prospective dome field, elongated north-south, and measuring 10 km by 2 km. The dome field contains 41 separate domes and is entirely covered by Allegiant’s claim block. Higher grade intercepts in drill hole 243 appear to be associated with stronger quartz veining than usual. Future work programs in the Original Pit Zone will focus on defining the extent of this high-grade zone to better understand the implications on resource growth and mine planning and economics.

See Eastside property map here:

Map 1: Eastside Property Map
https://www.allegiantgold.com/nr/2020-01-27-map.pdf

See Eastside (Original Pit Zone) Drilling Results here:

Table 1: Eastside Drilling Intercepts
https://www.allegiantgold.com/site/assets/files/3278/eastside_drilling_original_pit_zone_-_2021_drilling_i.pdf

See Eastside (Original Pit Zone) Drilling Map here:

Map 2: Eastside Drilling Map
https://allegiantgold.com/site/assets/files/2209/1550-eastside_planmap_5k_nad83zn11n.jpg

Map 3: Eastside Cross Sections
https://www.globenewswire.com/NewsRoom/AttachmentNg/e170db84-64d4-4e89-8dc1-c05cd72b0571

* The updated resource estimate (“Updated Resource Estimate and NI 43-101 Technical Report, Eastside and Castle Gold-Silver Project Technical Report, Esmeralda County, Nevada”) was conducted by Mine Development Associates (“MDA”) of Reno, Nevada with an effective date of December 30, 2019. Heap leach extractions are expected to be around 70% and 20% for gold and silver, respectively, using a three- stage crushing procedure. Milling with a fine grind is expected to result in extractions over 90% and around 50% for gold and silver, respectively. Utilizing a 0.15 g/t cut-off for Au, contained pit-constrained Inferred Resources of measured gold was 0.54 g/t and silver was 4.3 g/t. In accordance with NI 43-101 the MDA Technical Report dated January 24, 2020 will be filed on SEDAR. This report builds on and supersedes the NI 43-101 reports of Ristorcelli (December 2016) and Ristorcelli (July 2017) titled “Resource Estimate and Technical Report, Eastside Gold-Silver Project, Esmeralda County, Nevada” prepared for Allegiant with an Effective Date of July 25, 2017. A copy of the Eastside Technical Report can be found on SEDAR at www.sedar.com.

QUALIFIED PERSON

Andy Wallace is a Certified Professional Geologist (CPG) with the American Institute of Professional Geologists and is the Qualified Person under NI 43-101, Standards of Disclosure for Mineral Projects, who has reviewed and approved the scientific and technical content of this press release.

ABOUT ALLEGIANT

Allegiant owns 100% of 10 highly-prospective gold projects in the United States, 7 of which are located in the mining-friendly jurisdiction of Nevada. Four of Allegiant’s projects are farmed-out, providing for cost reductions and cash-flow. Allegiant’s flagship, district-scale Eastside project hosts a large and expanding gold resource and is located in an area of excellent infrastructure. Preliminary metallurgical testing indicates that both oxide and sulphide gold mineralization at Eastside is amenable to heap leaching.

ON BEHALF OF THE BOARD

Peter Gianulis
CEO

For more information contact:

Investor Relations
(604) 634-0970 or
1-888-818-1364
ir@allegiantgold.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements and information contained in this press release constitute “forward-looking statements” within the meaning of applicable U.S. securities laws and “forward-looking information” within the meaning of applicable Canadian securities laws, which are referred to collectively as “forward-looking statements”. The United States Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for certain forward-looking statements. Allegiant Gold Ltd.’s (“Allegiant”) exploration plans for its gold exploration properties, the drill program at Allegiant’s Eastside project, the preparation and publication of an updated resource estimate in respect of the Original Zone at the Eastside project, Allegiant’s future exploration and development plans, including anticipated costs and timing thereof; Allegiant’s plans for growth through exploration activities, acquisitions or otherwise; and expectations regarding future maintenance and capital expenditures, and working capital requirements.  Forward-looking statements are statements and information regarding possible events, conditions or results of operations that are based upon assumptions about future economic conditions and courses of action. All statements and information other than statements of historical fact may be forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “seek”, “expect”, “anticipate”, “budget”, “plan”, “estimate”, “continue”, “forecast”, “intend”, “believe”, “predict”, “potential”, “target”, “may”, “could”, “would”, “might”, “will” and similar words or phrases (including negative variations) suggesting future outcomes or statements regarding an outlook. Such forward-looking statements are based on a number of material factors and assumptions and involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or industry results, to differ materially from those anticipated in such forward-looking information. You are cautioned not to place undue reliance on forward-looking statements contained in this press release. Some of the known risks and other factors which could cause actual results to differ materially from those expressed in the forward-looking statements are described in the sections entitled “Risk Factors” in Allegiant’s Listing Application, dated January 24, 2018, as filed with the TSX Venture Exchange and available on SEDAR under Allegiant’s profile at www.sedar.com. Actual results and future events could differ materially from those anticipated in such statements. Allegiant undertakes no obligation to update or revise any forward-looking statements included in this press release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law.

Release – Comtech Telecommunications Corp. Awarded 1.6 Million Contract for High-Power Solid-State Amplifiers

Posted on by Admin


Comtech Telecommunications Corp. Awarded $1.6 Million Contract for High-Power Solid-State Amplifiers

 

MELVILLE, N.Y.–(BUSINESS WIRE)–May 26, 2021– 
May 26, 2021— 
Comtech Telecommunications Corp. (NASDAQ: CMTL), a world leader in secure wireless communications technologies, announced today that during its third quarter of fiscal 2021, its 
New York-based subsidiary, 
Comtech PST Corp., which is part of Comtech’s Government Solutions segment, was awarded an additional 
$1.6 million contract for RF microwave solid-state amplifiers from a major domestic prime contractor, adding to an initial 
$1.7 million contract awarded earlier this fiscal year.

These very high-power solid-state amplifiers, which utilize the latest in solid-state GaN transistor technology, were developed in close cooperation with the prime contractor and are part of a complex RF microwave transmission system used by the 
U.S. Military.

“This additional order is another example of Comtech’s technical strength in delivering high-power solid-state transmitter solutions for military applications and the ongoing demand for our high-power solid-state amplifier products,” said  Fred Kornberg, Chairman of the Board and Chief Executive Officer of 
Comtech Telecommunications Corp.

Comtech PST Corp. (www.comtechpst.com) is a leading independent supplier of broadband, high-power, high performance RF microwave amplifiers and control components for use in a broad spectrum of applications including defense, medical, satellite communications systems and instrumentation.

Comtech Telecommunications Corp. is a leader in the global communications market headquartered in 
Melville, New York. With a passion for customer success, 
Comtech designs, produces and markets advanced secure wireless solutions to more than 1,000 customers in more than 100 countries. For more information, please visit www.comtechtel.com.

Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s 
Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such 
Securities and Exchange Commission filings.

Media Contact:
Michael D. Porcelain, President and Chief Operating Officer

Comtech Telecommunications Corp.
631-962-7000
info@comtechtel.com

Source: 
Comtech Telecommunications Corp.

Release – PLBY Group Announces Successful Completion of Debt Refinancing

Posted on by Admin


PLBY Group Announces Successful Completion of Debt Refinancing

 

LOS ANGELES, May 25, 2021 (GLOBE NEWSWIRE) — PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today announced the successful completion of the refinancing of their existing credit facility through a $160 million senior secured term loan maturing in May 2027.

The new term loan will accrue interest at LIBOR plus 5.75%, with a single step-down to LIBOR plus 5.25% upon achieving gross leverage of 3.0x, subject to a LIBOR floor of 0.5%. The debt refinancing is expected to result in an estimated $3 million in annual interest expense savings, reduce amortization by over $3 million annually, and eliminate over $7 million in annual excess cash flow sweep payments. The refinancing also allows the Company to request to borrow at least $30 million of additional incremental term loans, and the Company may borrow unlimited additional amounts of pari passu debt as long as its senior secured leverage ratio is below 4.75x.

“We are pleased to further strengthen our financial flexibility by refinancing our existing facility with a new term loan that should reduce our annual debt service by over $13 million and which provides a defined path for additional borrowing to fund M&A,” said Lance Barton, Chief Financial Officer of PLBY Group. “Following the strength of our first quarter results, we are well-positioned to execute on both our organic and M&A growth initiatives and build upon our incredible global brand.”

About PLBY Group, Inc.
PLBY Group connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four major categories: Sexual Wellness, Style & Apparel, Gaming & Lifestyle, and Beauty & Grooming. PLBY Group’s flagship consumer brand, Playboy, is one of the most recognizable, iconic brands in the world, driving billions of dollars in consumer spending annually across 180 countries. Learn more at http://www.plbygroup.com.

Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from their expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s expectations with respect to future performance, growth plans and anticipated financial impacts of the Company’s recent business combination and its acquisitions.

These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Factors that may cause such differences include, but are not limited to: (1) the impact of COVID-19 pandemic on the Company’s business; (2) the inability to maintain the listing of the Company’s shares of common stock on Nasdaq; (3) the risk that the business combination, recent acquisitions or any proposed transactions disrupt the Company’s current plans and operations, including the risk that the Company does not complete any such proposed transactions or achieve the expected benefits from them; (4) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth profitably, and retain its key employees; (5) costs related to the business combination, acquisitions and proposed transactions; (6) changes in applicable laws or regulations; (7) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; (8) risks relating to the uncertainty of the projected financial information of the Company; (9) risks related to the organic and inorganic growth of the Company’s business and the timing of expected business milestones; and (10) other risks and uncertainties indicated from time to time in the Company’s annual report on Form 10-K, including those under “Risk Factors” therein, and in the Company’s other filings with the Securities and Exchange Commission. The Company cautions that the foregoing list of factors is not exclusive, and readers should not place undue reliance upon any forward-looking statements, which speak only as of the date which they were made. The Company does not undertake any obligation to update or revise any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.

Contact:

Investors: investors@plbygroup.com
Media: press@plbygroup.com

Palladium One Drills Haukiaho Trend, Intercepts 72 Meters @ 1.8 g/t Palladium-Equivalent, Finland

Posted on by Admin


Palladium One Drills Haukiaho Trend, Intercepts 72 Meters @ 1.8 g/t Palladium-Equivalent, Finland

 

May 26, 2021 – Toronto, Ontario – First drill results from the Company’s 2,000 meter drill program at Haukiaho, a zone approximately 20 kilometers south of the Company’s primary target area Kaukua South, have returned  significant widths and grades, including 72 meters at 1.8 g/t Palladium-equivalent “Pd_Eq”) (Hole LK21-071), on the Läntinen Koillismaa “LK”) PGE-Ni-Cu project in Finland, said Palladium One Mining Inc. “Palladium One” or the “Company”) (TSXV: PDM, FRA: 7N11, OTC: NKORF) today.

A total of 12 holes (1,943 metres) were drilled on the Haukiaho trend. This release contains the results from the first 7 holes of this program. The drilling was designed establish sufficient drill density to prepare a National Instrument 43-101 resource estimate at Haukiaho, which the Company anticipates completing in Q3 2021.

“Establishing a NI43-101 resource estimate at Haukiaho has been a priority for the Company given the robust historical data set available to the Company. Haukiaho was the original focus of the Phase I drill program in 2020, however, the discovery of Kaukua South led us towards first defining the potential of this new discovery and exploring the greater Kaukua area.  Despite this, Haukiaho was not forgotten and has remained an important part of our strategy to grow a multi-million ounce resource base. At 17 kilometers in length, the Haukiaho trend, currently represents the largest continuous patch of blue-sky potential on the LK property.” said Derrick Weyrauch, President and CEO.

Highlights

  • Drilling has returned significant widths and grades
  • Expanded higher grade areas within the known historic Haukiaho resource area
  • Expanded mineralization 100m to east of the historic resource
  • 72.2 meters grading 1.79 g/t Pd_Eq in hole LK21-071 starting 56m down hole, including 17.0 meters grading 2.23 g/t Pd_Eq
  • 15.7 meters grading 2.26 g/t Pd_Eq in hole LK21-069 including 3.6 meters grading 3.11 g/t Pd_Eq
  • 51.2 meters grading 1.07 g/t Pd_Eq in hole LK21-073 including 9.1 meters grading 2.10 g/t Pd_Eq
  • The historic Haukiaho resource is shallowly drilled, mostly above 200m in depth and therefore amendable to open pit mining

Haukiaho Historic Resource Estimate

In the 1980’s, Outokumpu  (a Finnish State-run mining company) prepared a resource estimate using very widely spaced holes along a portion of the Haukiaho trend, which estimated 7 million tonnes grading 0.38% Cu and 0.24% Ni, however importantly, no PGE assays were undertaken. The cut-off grade used was a 0.7% Copper_equivalent (defined as Cu% + 2 x Ni%).

Subsequently in 2013, Finore Mining Inc. completed a non-pit constrained NI43-101 historic resource estimate, over a much smaller strike length.  Using  a 0.1 g/t Pd cut-off, they estimated a resource of 1.13 million Pd_Eq ounces within 23.2 million tonnes grading 1.51 g/t Pd_Eq (0.31 g/t Pd, 0.12g/t Pt, 0.10 g/t Au, 0.21% Cu, and 0.14% Ni) (See news release August 12, 2019 and May 7, 2020).  This resource estimate encompassed widely spaced drilling with a focus on maximizing tonnage, not grade.

The Haukiaho trend is 17 kilometers long and the historic 2013 Haukiaho resource prepared by Finore covers less than 2 kilometers of this trend.  This knowledge coupled with the historic work by Outokumpu point to the enormous potential to significantly add resources at Haukiaho with disciplined execution of exploration activities.

While similar to the Kaukua deposit (See new release, September 30, 2019), the Haukiahio trend is more copper-nickel rich.  At Kaukua, approximately ~1/3 of the in-situ value per tonne is copper-nickel, while at Haukiaho copper-nickel represent approximately ~2/3s of the in-situ value.

Figure 1. LK Project location map showing 43-101 compliant Kaukua deposit and historic Haukiaho resource along with 2020 IP grids (blue lines) and current 2021 IP grid areas (black boxes). Yellow lines represent Exploration Permits, red lines represent Exploration Reservations held by the Company.

Figure 2. Plan map of Haukiaho 2020 IP chargeability anomalies and Palladium One drill holes locations.

Figure 3. Plan map of the Haukiaho historic 2013 Finore resource estimate represented by the > 0.5g/t Pd_Eq resource shape with Palladium One drill holes.

Figure 4. Haukiaho Cross section showing holes LK21-071, Finore hole HAU11-005, and geological survey of Finland (GTK) holes R-390 and R-389.

Table 1: Palladium One Haukiaho drill results

Hole

From
(m)

To
(m)

Width
(m)

Pd_Eq
g/t*

Pd
g/t

Pt
g/t

Au
g/t

Cu
%

Ni
%

LK20-008

17.3

33.5

16.2

1.99

0.38

0.15

0.14

0.26

0.20

Inc.

20.3

23.3

3.0

2.55

0.48

0.19

0.22

0.33

0.25

LK20-009

161.5

168.1

6.6

2.34

0.47

0.20

0.13

0.26

0.25

LK20-010

118.7

202.0

83.3

1.27

0.24

0.09

0.05

0.12

0.16

Inc.

166.8

201.0

34.3

2.09

0.47

0.20

0.10

0.20

0.22

Inc.

167.8

173.0

5.3

3.08

0.66

0.25

0.20

0.38

0.30

Inc.

20.3

23.3

3.0

2.55

0.48

0.19

0.22

0.33

0.25

LK21-067

No Significant values (collared in footwall rocks)

LK21-068

81.5

122.0

40.6

0.65

0.05

0.02

0.02

0.04

0.11

Inc.

106.2

120.0

13.9

0.80

0.12

0.05

0.02

0.06

0.12

Inc.

106.2

112.7

6.6

0.91

0.13

0.05

0.03

0.09

0.13

LK21-069

48.5

64.1

15.7

2.26

0.47

0.18

0.18

0.27

0.22

Inc.

48.5

60.0

11.6

2.53

0.52

0.19

0.18

0.30

0.25

Inc.

48.5

52.0

3.6

3.11

0.60

0.22

0.23

0.37

0.32

LK21-070

103.5

131.0

27.5

0.65

0.01

0.00

0.02

0.04

0.12

Inc.

113.0

119.0

6.0

0.83

0.02

0.00

0.04

0.09

0.14

LK21-071

55.8

128.0

72.2

1.79

0.37

0.15

0.14

0.22

0.17

Inc.

72.0

77.0

5.0

2.33

0.53

0.21

0.18

0.27

0.22

Inc.

74.0

75.5

1.5

3.20

0.75

0.29

0.23

0.39

0.29

And

86.2

94.0

7.8

2.74

0.53

0.21

0.23

0.32

0.27

And

111.0

128.0

17.0

2.23

0.53

0.21

0.18

0.28

0.18

Inc.

112.5

118.0

5.5

2.84

0.64

0.25

0.23

0.36

0.25

LK21-072

No Significant values (ended before zone)

LK21-073

75.8

127.0

51.2

1.07

0.15

0.06

0.06

0.13

0.13

Inc.

90.0

113.1

23.1

1.51

0.25

0.10

0.10

0.21

0.16

Inc.

90.8

99.9

9.1

2.10

0.37

0.15

0.16

0.27

0.21

Inc.

98.0

99.0

1.0

3.21

0.61

0.27

0.29

0.47

0.28

LK21-074

Pending

LK21-075

Pending

LK21-076

Pending

LK21-077

Pending

LK21-078

Pending

* Reported widths are “drilled widths” not true widths.
**Italicised orange highlighted results are previously released results see news release September 15, 2020

*Palladium Equivalent
Palladium equivalent is calculated using US$1,100 per ounce for palladium, US$950 per ounce for platinum, US$1,300 per ounce for gold, US$6,614 per tonne for copper, and US$15,4332 per tonne for nickel. This calculation is consistent with the calculation in the Company’s September 2019 NI 43-101 Kaukua resource estimate. Additionally, US$1,100 per ounce for palladium is consistent with the UBS January 2021 long-term consensus price forecast even though the current price of palladium is approximately US$2,800 per ounce.

QA/QC
The Phase I drilling program was carried out under the supervision of Neil Pettigrew, M.Sc., P. Geo., Vice President of Exploration and a director of the Company.

Drill core samples were split using a rock saw by Company staff, with half retained in the core box and stored indoors in a secure facility, in Taivalkoski, Finland. The drill core samples were transported by courier from the Company’s core handling facility in Taivalkoski, Finland, to ALS Global “ALS”) laboratory in Outokumpu, Finland. ALS, is an accredited lab and are ISO compliant (ISO 9001:2008, ISO/IEC 17025:2005). PGE analysis was performed using a 30 grams fire assay with an ICP-MS or ICP-AES finish. Multi-element analyses, including copper and nickel were analysed by four acid digestion using 0.25 grams with an ICP-AES finish.

Certified standards, blanks and crushed duplicates are placed in the sample stream at a rate of one QA/QC sample per 10 core samples. Results are analyzed for acceptance at the time of import. All standards associated with the results in this press release were determined to be acceptable within the defined limits of the standard used.

Qualified Person
The technical information in this release has been reviewed and verified by Neil Pettigrew, M.Sc., P. Geo., Vice President of Exploration and a director of the Company and the Qualified Person as defined by National Instrument 43-101.

About Palladium One
Palladium One Mining Inc. is an exploration company targeting district scale, platinum-group-element (PGE)-copper nickel deposits in Finland and Canada. Its flagship project is the Läntinen Koillismaa or LK Project, a palladium dominant platinum group element-copper-nickel project in north-central Finland, ranked by the Fraser Institute as one of the world’s top countries for mineral exploration and development. Exploration at LK is focused on targeting disseminated sulfides along 38 kilometers of favorable basal contact and building on an established NI 43-101 open pit resource.

ON BEHALF OF THE BOARD
“Derrick Weyrauch”
President & CEO, Director

For further information contact: Derrick Weyrauch, President & CEO
Email: info@palladiumoneinc.com

Neither the TSX Venture Exchange nor its Market Regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release includes “forward-looking information” that is subject to a few assumptions, risks and uncertainties, many of which are beyond the control of the Company. Statements regarding listing of the Company’s common shares on the TSXV are subject to all of the risks and uncertainties normally incident to such events. Investors are cautioned that any such statements are not guarantees of future events and that actual events or developments may differ materially from those projected in the forward-looking statements. Such forward-looking statements represent management’s best judgment based on information currently available. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions and general business conditions. Such forward-looking information reflects the Company’s views with respect to future events and is subject to risks, uncertainties and assumptions, including those set out in the Company’s annual information form dated April 29, 2020 and filed under the Company’s profile on SEDAR at www.sedar.com. The Company does not undertake to update forward?looking statements or forward?looking information, except as required by law. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements.

TAAL Distributed Information Technologies (TAALF) – Initiating Coverage on TAAL Distributed – Blockchain for Enterprise

Posted on by Admin

Wednesday, May 26, 2021

TAAL Distributed Information Technologies (TAALF)
Initiating Coverage on TAAL Distributed – Blockchain for Enterprise

Taal Distributed Information Technologies Inc delivers value-added blockchain services, providing professional-grade, highly scalable blockchain infrastructure and transactional platforms to support businesses building solutions and applications upon the Bitcoin SV platform, and developing, operating, and managing distributed computing systems for enterprise users.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Initiating Coverage. We are initiating research coverage on TAAL Distributed Information Technologies. We believe the Company’s focus on using blockchain for transaction processing will bring long-term value, while crypto mining services provide near-term revenue and an option on rising prices for BitcoinSV.

    A Differentiated Approach to Blockchain.  TAAL’s goal is to harness the power of blockchain processing for enterprise applications. The Company’s proprietary cloud-based platform meets enterprise demand for real-time transactions, unlimited transaction scalability, ultra low transaction fees, and network security on the blockchain …



    Get The Full Report

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

Posted on by Admin


Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

 

– Clinical study evaluating the well-known health claims of beta glucan and its potentially beneficial approach for patients to lower plasma cholesterol –

– Study conducted in collaboration with the Montreal Heart Institute and led by MHI’s Montreal Health Innovations Coordinating Center (MHICC) –

– Topline data readout expected Q4 2021 –

EDMONTON, Alberta, May 26, 2021 (GLOBE NEWSWIRE) —  Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced the completion of patient enrollment in its comparison study evaluating high-medium molecular weight beta glucan as a stand-alone or add-on therapy to statins (the “BetAvena study”) in subjects with hyperlipidemia.

The study is being conducted with the Montreal Heart Institute (MHI), led by Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute Research Center and Principal Investigator for this clinical trial as part of a long-term collaboration.

“We are incredibly pleased with the flawless execution of this important clinical study, despite challenges posed by the COVID-19 pandemic. We are extremely grateful to Dr. Jean-Claude Tardif and his expert team at the Montreal Heart Institute and their dedication to getting this study across the finish line and providing the opportunity to assess and validate the well-known health benefits of beta glucan per the highest clinical practice standards. The amended protocol that we were granted for the study expanded our target addressable patient population, which provided both scientific and clinical value and aided in successfully completing patient enrollment. This is a major milestone for our Company as we expand as a biopharmaceutical company and we look forward to reporting topline data in the fourth quarter of this year,” stated Gilles Gagnon, M.Sc., MBA, President and CEO.

“With patient enrollment now complete, our team is focused on advancing this potential alternative treatment forward and bring the study to successful completion. Pending statistical review, the BetAvena study may represent a significant shift for the patient community hoping to achieve hyperlipidemia control with nutraceuticals such as Ceapro’s CP105F. We are impressed by the engagement of our clinical sites and our patients who had to compose with very difficult COVID circumstances,” added Dr. Tardif.

This multicenter, randomized, double-blind, parallel group, placebo-controlled study is conducted to determine the efficacy and safety of high-medium molecular weight beta glucan in subjects with hyperlipidemia (LDL-C level >130 mg/d L (3.37 mmol/L). The 18 to 24-month study enrolled approximately 264 subjects who cannot tolerate high doses of current treatments. The Company received approval from Health Canada in February 2020 to expand the inclusion criteria of the study to allow evaluation of enrolled subjects with confirmed pathophysiological condition of hyperlipidemia who voluntarily request to be treated with beta glucan only, without regular dosing of statins. Enrolled patients were randomized to receive either placebo, low, medium or high doses of beta glucan (500 mg tablet) as add-on therapy, or not, to atorvastatin 10 mg – 20 mg or an equivalent statin for a 12-week treatment period. The primary efficacy endpoint of the study is the change over 12 weeks in LDL-cholesterol.

The Company anticipates the statistical analysis to be completed this fall and subsequently submitted to Heath Canada. The Company expects to report topline data from the study in the fourth quarter of 2021.

About Ceapro Inc.

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.

For more information contact:

Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com

Issuer:
Gilles R. Gagnon, M.Sc., MBA
President & CEO
T: 780-421-4555

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release


Source: Ceapro Inc.

Comtech Telecommunications Corp. Awarded $1.6 Million Contract for High-Power Solid-State Amplifiers

Posted on by Admin


Comtech Telecommunications Corp. Awarded $1.6 Million Contract for High-Power Solid-State Amplifiers

 

MELVILLE, N.Y.–(BUSINESS WIRE)–May 26, 2021– 
May 26, 2021— 
Comtech Telecommunications Corp. (NASDAQ: CMTL), a world leader in secure wireless communications technologies, announced today that during its third quarter of fiscal 2021, its 
New York-based subsidiary, 
Comtech PST Corp., which is part of Comtech’s Government Solutions segment, was awarded an additional 
$1.6 million contract for RF microwave solid-state amplifiers from a major domestic prime contractor, adding to an initial 
$1.7 million contract awarded earlier this fiscal year.

These very high-power solid-state amplifiers, which utilize the latest in solid-state GaN transistor technology, were developed in close cooperation with the prime contractor and are part of a complex RF microwave transmission system used by the 
U.S. Military.

“This additional order is another example of Comtech’s technical strength in delivering high-power solid-state transmitter solutions for military applications and the ongoing demand for our high-power solid-state amplifier products,” said  Fred Kornberg, Chairman of the Board and Chief Executive Officer of 
Comtech Telecommunications Corp.

Comtech PST Corp. (www.comtechpst.com) is a leading independent supplier of broadband, high-power, high performance RF microwave amplifiers and control components for use in a broad spectrum of applications including defense, medical, satellite communications systems and instrumentation.

Comtech Telecommunications Corp. is a leader in the global communications market headquartered in 
Melville, New York. With a passion for customer success, 
Comtech designs, produces and markets advanced secure wireless solutions to more than 1,000 customers in more than 100 countries. For more information, please visit www.comtechtel.com.

Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s 
Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such 
Securities and Exchange Commission filings.

Media Contact:
Michael D. Porcelain, President and Chief Operating Officer

Comtech Telecommunications Corp.
631-962-7000
info@comtechtel.com

Source: 
Comtech Telecommunications Corp.

Release – Allegiant Discovers Bonanza Gold and Silver Grades at Eastside

Posted on by Admin


Allegiant Discovers Bonanza Gold and Silver Grades at Eastside

 

  • HOLE 243 – 148 METRES (486 FEET) OF 2.6 G/T GOLD
    (including 14 METRES (45 FEET) OF 21.9 G/T GOLD)
    (including 20 METRES (65 FEET) OF 173.8 G/T SILVER)
  • HOLE 239 – 3 METRES (10 FEET) OF 39.0 G/T GOLD

RENO, Nev., May 26, 2021 (GLOBE NEWSWIRE) — Allegiant Gold Ltd. (“Allegiant” or the “Company”) (AUAU: TSX-V) (AUXXF: OTCQX) is very pleased to announce bonanza grades in the best drill results to date in the Original Pit Zone, at the 100% owned Eastside gold project in Nevada.   Eastside presently hosts a current NI 43-101 pit-constrained Inferred resource of 996,000 ounces of gold and 7.8 million ounces of silver* and is open in all directions.

Peter Gianulis, CEO of Allegiant Gold, commented: “The results from the recent drill program at Eastside are simply the best received since Allegiant made the initial discovery. The project has exceeded our expectations and continues to improve and positively surprise us with its potential. We remain focused on executing our business plan and are well on our way to outlining a multi-million-ounce deposit at Eastside.”

Highlights of the 9-hole (3,673 metres) RC drill program:

  • Hole 243 included 2.55 g/t Au over 147.8 metres (3.17 g/t Au over 117.3m)
  • Hole 243 is the best drill intercept to date at the project
  • Hole 243 was a 100m step-out from the closest hole in the Original Pit and is open west, east and south
  • Hole 243 is well within an open-pit modeling scenario
  • Significant silver in Holes 243 and 239
  • Strong gold intercepts in Holes 239, 243, 244 and 245
  • Mineralization encountered in 7 of 9 holes
  • Eastside remains open in all directions and at depth in both the Original Pit Zone and the Castle Zone

Allegiant has drilled over 210 holes over the past 8 years in building a significant 1mm ounce gold inferred resource. Over 284 metres of the 428 metres drilled were mineralized in Hole 243 and, utilizing a 0.10 g/t Au cut-off, the hole delivered 2.55 g/t Au over 147.8 metres (3.17 g/t Au over 117.3m using a 0.20 g/t Au cut-off) commencing from a depth of 172 metres. Equally important is that Hole 243 ended in gold mineralization, with the bottom running 12.2m of 2.24 g/t Au (within a 55m interval of 0.92 g/t Au). Excellent silver mineralization was also encountered (see comment on Significant Silver Intercepts below).

Strong Gold Intercepts in Hole 239, 244 and 245
The success during the recent drill program was not limited solely to Hole 243. Excellent grades and intercepts were found in additional holes with strong mineralization occurring at the bottom of the holes implying the deposit continues to remain open at depth.

  Hole 239 111.3m of 1.45 g/t Au including 3.1 metres of 39 g/t at the bottom of the hole.
  Hole 244 76 metres of hole is mineralized with best intercept being 6.1m of 1.48 g/t Au
  Hole 245 32 metres of 3.4 g/t Au from relatively shallow depths (177m)

Significant Silver Intercepts in Holes 239, 243 and 244
Excellent silver intercepts were also encountered during this most recent drilling program. Using a 10 g/t Ag cutoff, Hole 239 encountered 6.1 metres of 113.35 g/t Ag at the bottom of the hole leading us to believe that it remains wide-open at depth. In Hole 243, an intercept of 93.3 g/t Ag over 44.2 metres was identified. Other silver intercepts were found in Hole 241 and Hole 244. The Original Pit Zone at Eastside hosts approximately 7.8 million ounces of silver per the most recent 43-101 compliant resource estimate dated January 2020. Allegiant continues to believe that there remains significant upside potential to discover additional silver, though gold continues to be the primary mineralization.

Geological Comment
Gold and silver at the Original Pit Zone is hosted mainly in young rhyolite domes and dikes (7.2 MYBP) cutting through andesite flows and lahar, lacustrine tuffs, and rhyodacite flows and plugs. Eighty five percent of the drilled gold intercepts are hosted in rhyolite. Important alteration includes multiple generations of quartz in stock works, replacement illite, adularia (both as flooding and in veins), and a variety of iron oxides mostly filling fractures. The domes at the Original Pit are the northernmost two of a highly prospective dome field, elongated north-south, and measuring 10 km by 2 km. The dome field contains 41 separate domes and is entirely covered by Allegiant’s claim block. Higher grade intercepts in drill hole 243 appear to be associated with stronger quartz veining than usual. Future work programs in the Original Pit Zone will focus on defining the extent of this high-grade zone to better understand the implications on resource growth and mine planning and economics.

See Eastside property map here:

Map 1: Eastside Property Map
https://www.allegiantgold.com/nr/2020-01-27-map.pdf

See Eastside (Original Pit Zone) Drilling Results here:

Table 1: Eastside Drilling Intercepts
https://www.allegiantgold.com/site/assets/files/3278/eastside_drilling_original_pit_zone_-_2021_drilling_i.pdf

See Eastside (Original Pit Zone) Drilling Map here:

Map 2: Eastside Drilling Map
https://allegiantgold.com/site/assets/files/2209/1550-eastside_planmap_5k_nad83zn11n.jpg

Map 3: Eastside Cross Sections
https://www.globenewswire.com/NewsRoom/AttachmentNg/e170db84-64d4-4e89-8dc1-c05cd72b0571

* The updated resource estimate (“Updated Resource Estimate and NI 43-101 Technical Report, Eastside and Castle Gold-Silver Project Technical Report, Esmeralda County, Nevada”) was conducted by Mine Development Associates (“MDA”) of Reno, Nevada with an effective date of December 30, 2019. Heap leach extractions are expected to be around 70% and 20% for gold and silver, respectively, using a three- stage crushing procedure. Milling with a fine grind is expected to result in extractions over 90% and around 50% for gold and silver, respectively. Utilizing a 0.15 g/t cut-off for Au, contained pit-constrained Inferred Resources of measured gold was 0.54 g/t and silver was 4.3 g/t. In accordance with NI 43-101 the MDA Technical Report dated January 24, 2020 will be filed on SEDAR. This report builds on and supersedes the NI 43-101 reports of Ristorcelli (December 2016) and Ristorcelli (July 2017) titled “Resource Estimate and Technical Report, Eastside Gold-Silver Project, Esmeralda County, Nevada” prepared for Allegiant with an Effective Date of July 25, 2017. A copy of the Eastside Technical Report can be found on SEDAR at www.sedar.com.

QUALIFIED PERSON

Andy Wallace is a Certified Professional Geologist (CPG) with the American Institute of Professional Geologists and is the Qualified Person under NI 43-101, Standards of Disclosure for Mineral Projects, who has reviewed and approved the scientific and technical content of this press release.

ABOUT ALLEGIANT

Allegiant owns 100% of 10 highly-prospective gold projects in the United States, 7 of which are located in the mining-friendly jurisdiction of Nevada. Four of Allegiant’s projects are farmed-out, providing for cost reductions and cash-flow. Allegiant’s flagship, district-scale Eastside project hosts a large and expanding gold resource and is located in an area of excellent infrastructure. Preliminary metallurgical testing indicates that both oxide and sulphide gold mineralization at Eastside is amenable to heap leaching.

ON BEHALF OF THE BOARD

Peter Gianulis
CEO

For more information contact:

Investor Relations
(604) 634-0970 or
1-888-818-1364
ir@allegiantgold.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements and information contained in this press release constitute “forward-looking statements” within the meaning of applicable U.S. securities laws and “forward-looking information” within the meaning of applicable Canadian securities laws, which are referred to collectively as “forward-looking statements”. The United States Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for certain forward-looking statements. Allegiant Gold Ltd.’s (“Allegiant”) exploration plans for its gold exploration properties, the drill program at Allegiant’s Eastside project, the preparation and publication of an updated resource estimate in respect of the Original Zone at the Eastside project, Allegiant’s future exploration and development plans, including anticipated costs and timing thereof; Allegiant’s plans for growth through exploration activities, acquisitions or otherwise; and expectations regarding future maintenance and capital expenditures, and working capital requirements.  Forward-looking statements are statements and information regarding possible events, conditions or results of operations that are based upon assumptions about future economic conditions and courses of action. All statements and information other than statements of historical fact may be forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “seek”, “expect”, “anticipate”, “budget”, “plan”, “estimate”, “continue”, “forecast”, “intend”, “believe”, “predict”, “potential”, “target”, “may”, “could”, “would”, “might”, “will” and similar words or phrases (including negative variations) suggesting future outcomes or statements regarding an outlook. Such forward-looking statements are based on a number of material factors and assumptions and involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or industry results, to differ materially from those anticipated in such forward-looking information. You are cautioned not to place undue reliance on forward-looking statements contained in this press release. Some of the known risks and other factors which could cause actual results to differ materially from those expressed in the forward-looking statements are described in the sections entitled “Risk Factors” in Allegiant’s Listing Application, dated January 24, 2018, as filed with the TSX Venture Exchange and available on SEDAR under Allegiant’s profile at www.sedar.com. Actual results and future events could differ materially from those anticipated in such statements. Allegiant undertakes no obligation to update or revise any forward-looking statements included in this press release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law.

HCA Healthcare Partners with Google Cloud to Accelerate Digital Transformation

Posted on by Admin 

image credit: Panodex - BigQuery (Flickr)


Medical and Tech Giants to Apply AI to Records for Actionable Care Insights

 

Google (GOOG) and HCA Healthcare (HCA) just announced (May 26) a partnership to build on HCA Healthcare’s use of information technology to further their transformation to benefit from collected patient data. According to an HCA press release, “The partnership with Google Cloud is designed to help create a secure and dynamic data analytics platform for HCA Healthcare and enable the development of next generation operational models focused on actionable insights and improved workflows.”

Under the plan, HCA’s 2,000 locations in 21 states would consolidate and store digital health records along with information from internet-connected medical devices with Google Data. The multiyear agreement will require Google and HCA engineers to work to help improve operating efficiency, monitor patients and guide doctors’ decisions.


Patients Privacy and Providing Data

The company said, “While protecting patient privacy and the security of data, HCA Healthcare uses information from its 32 million annual encounters to identify opportunities to improve clinical care and support its 93,000 nurses and 47,000 active and affiliated physicians.” The data collected can be valuable for the hospital chain while at the same time serve to better inform global medical care.  HCA Healthcare has published studies in leading medical journals like the New England Journal of Medicine and The Lancet, developed algorithm-informed decision support tools for caregivers, and identified clinical practices that reduce infections and improve perinatal care. The partnership with Google Cloud is expected to enhance efforts by HCA to continue to improve and develop advanced decision support to promote quality, safety, and efficiency.


Data Science in Medicine

Data generated by hospitals places them in an enviable position as brokers of this information.  Patients under their care, being seen by doctors, labs, pharmacies, and monitored by medical devices, provide records of treatment, behavior, patterns, and results. This information, fed through algorithms developed by data-mining companies, can serve as a revenue source as it may be sold to pharmaceutical and technology companies. The data-mining companies involved include large companies like Google right down start-ups where the profits are more impactful on financials. The results, if done with strict control over privacy, can be win-win-win as patient care improves, hospitals benefit, and tech companies provide solutions.

 

 

Looking Toward the Future

“The cloud can be an accelerant for innovation in health, particularly in driving data interoperability, which is critical in streamlining operations and providing better quality of care to improve patient outcomes,” said Thomas Kurian, CEO, Google Cloud Sam Hazen, CEO of HCA healthcare stated, “Next-generation care demands data science-informed decision support so we can more sharply focus on safe, efficient and effective patient care.”  The cloud-based network is intended to allow clinicians to rely on it for on-the-fly decisions, as well as medical staff in more controlled settings.

HCA Healthcare has deployed 90,000 mobile devices that run tools created by the organization’s PatientKeeper and Mobile Heartbeat teams and other developers to empower caregivers. The partnership with Google Cloud is expected to empower physicians, nurses and others with workflow tools, analysis and alerts on their mobile devices to help clinicians respond quickly to changes in a patient’s condition.

This is an opportunity for both partnered companies to benefit while, with sufficient safety and security measures in place, positively impact care patients receive.

 

Suggested Reading:

What Cells Can be Made From Stem Cells

Cannabis Customers Served by “Ice Cream Truck” Model



Scientists Now Better Understand Viral Mutations

The Case for Investing in Regenerative Medicine

 

Sources:

https://investor.hcahealthcare.com/news/news-details/2021/HCA-Healthcare-Partners-With-Google-Cloud-to-Accelerate-Digital-Transformation/default.aspx

https://www.wsj.com/articles/google-strikes-deal-with-hospital-chain-to-develop-healthcare-algorithms-11622030401?mod=hp_lead_pos1

 

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Seanergy Maritime (SHIP) – Solid Quarter Sets Positive Tone for Year

Posted on by Admin

Wednesday, May 26, 2021

Seanergy Maritime (SHIP)
Solid Quarter Sets Positive Tone for Year

Seanergy Maritime Holdings Corp., an international shipping company, provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. Seanergy Maritime Holdings Corp. is the only pure-play Capesize shipping company listed in the US capital markets. Seanergy provides marine dry bulk transportation services through a modern fleet of 10 Capesize vessels, with total capacity of approximately 1,748,581 dwt and an average fleet age of about 9.8 years. The Company is incorporated in the Marshall Islands with executive offices in Athens, Greece and an office in Hong Kong. The Company’s common shares trade on the Nasdaq Capital Market under the symbol “SHIP” and class A warrants under “SHIPW”.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    1Q2021 EBITDA of $6.5 million was ahead of our estimate is $5.7 million due to higher average TCE rates of $16.2k/day. TCE revenue of $15.1 million was $0.9 million higher due to a positive rate variance and opex of $5.6 million was about $0.5 million lower than expected, which more than offset higher G&A expense of $2.7 million.

    Fine tuning 2021 EBITDA estimate to $81.4 million based on TCE rates of $24.9k/day versus our prior estimate of $77.1 million based on TCE rates of $26.8/day to reflect 1Q2021 results, updated forward cover and the timing of the pending acquisitions.  2Q2021 forward cover is high at 96% of available days booked at an average TCE rate of $22.4k/day. Please note that the average TCE rate is a blend of …



    Get The Full Report

This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

Posted on by Admin


Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent

 

– Clinical study evaluating the well-known health claims of beta glucan and its potentially beneficial approach for patients to lower plasma cholesterol –

– Study conducted in collaboration with the Montreal Heart Institute and led by MHI’s Montreal Health Innovations Coordinating Center (MHICC) –

– Topline data readout expected Q4 2021 –

EDMONTON, Alberta, May 26, 2021 (GLOBE NEWSWIRE) —  Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced the completion of patient enrollment in its comparison study evaluating high-medium molecular weight beta glucan as a stand-alone or add-on therapy to statins (the “BetAvena study”) in subjects with hyperlipidemia.

The study is being conducted with the Montreal Heart Institute (MHI), led by Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute Research Center and Principal Investigator for this clinical trial as part of a long-term collaboration.

“We are incredibly pleased with the flawless execution of this important clinical study, despite challenges posed by the COVID-19 pandemic. We are extremely grateful to Dr. Jean-Claude Tardif and his expert team at the Montreal Heart Institute and their dedication to getting this study across the finish line and providing the opportunity to assess and validate the well-known health benefits of beta glucan per the highest clinical practice standards. The amended protocol that we were granted for the study expanded our target addressable patient population, which provided both scientific and clinical value and aided in successfully completing patient enrollment. This is a major milestone for our Company as we expand as a biopharmaceutical company and we look forward to reporting topline data in the fourth quarter of this year,” stated Gilles Gagnon, M.Sc., MBA, President and CEO.

“With patient enrollment now complete, our team is focused on advancing this potential alternative treatment forward and bring the study to successful completion. Pending statistical review, the BetAvena study may represent a significant shift for the patient community hoping to achieve hyperlipidemia control with nutraceuticals such as Ceapro’s CP105F. We are impressed by the engagement of our clinical sites and our patients who had to compose with very difficult COVID circumstances,” added Dr. Tardif.

This multicenter, randomized, double-blind, parallel group, placebo-controlled study is conducted to determine the efficacy and safety of high-medium molecular weight beta glucan in subjects with hyperlipidemia (LDL-C level >130 mg/d L (3.37 mmol/L). The 18 to 24-month study enrolled approximately 264 subjects who cannot tolerate high doses of current treatments. The Company received approval from Health Canada in February 2020 to expand the inclusion criteria of the study to allow evaluation of enrolled subjects with confirmed pathophysiological condition of hyperlipidemia who voluntarily request to be treated with beta glucan only, without regular dosing of statins. Enrolled patients were randomized to receive either placebo, low, medium or high doses of beta glucan (500 mg tablet) as add-on therapy, or not, to atorvastatin 10 mg – 20 mg or an equivalent statin for a 12-week treatment period. The primary efficacy endpoint of the study is the change over 12 weeks in LDL-cholesterol.

The Company anticipates the statistical analysis to be completed this fall and subsequently submitted to Heath Canada. The Company expects to report topline data from the study in the fourth quarter of 2021.

About Ceapro Inc.

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.

For more information contact:

Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com

Issuer:
Gilles R. Gagnon, M.Sc., MBA
President & CEO
T: 780-421-4555

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release


Source: Ceapro Inc.

Energy Fuels (UUUU)(EFR:CA) – Rating Upgraded and New Price Target Established

Posted on by Admin

Wednesday, May 26, 2021

Energy Fuels (UUUU)(EFR:CA)
Rating Upgraded, New Price Target

As of April 24, 2020, Noble Capital Markets research on Energy Fuels is published under ticker symbols (UUUU and EFR:CA). The price target is in USD and based on ticker symbol UUUU. Research reports dated prior to April 24, 2020 may not follow these guidelines and could account for a variance in the price target.

Energy Fuels is the largest uranium producer in the U.S. and holds more production capacity and uranium resources than any other U.S. producer. The Company also produces vanadium. Headquartered in Colorado, Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch ISR Facility in Wyoming, and the Alta Mesa ISR Facility in Texas. The producing White Mesa Mill is the only conventional uranium mill in the U.S. and has a licensed capacity of 8 million pounds of U3O8 per year. Nichols Ranch is in production and has a licensed capacity of 2 million pounds of U3O8 per year. Alta Mesa is currently on standby. Energy Fuels also owns several licensed and developed uranium and vanadium mines on standby and other projects in development.

Michael Heim, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    We are upgrading our rating on the shares of Energy Fuels and establishing a new price target. The upgrade reflects an increased recognition of the value of Energy Fuel’s Rate Earth Element (REE) strategy as well as a belief that the company is well positioned to take advantage of an expected increase in uranium prices.

    The success of Energy Fuels and its stock price is largely tied to the success of the domestic uranium industry.  If uranium prices return to historical levels above $50 per pound, all domestic uranium companies including Energy Fuels will do well. We believe such a move will occur in the next few years in response to rising demand and decreasing international supply of uranium. We believe Energy …



    Get The Full Report

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.